S. Raper

发表

Safety of intrapleurally administered recombinant adenovirus carrying herpes simplex thymidine kinase DNA followed by ganciclovir therapy in nonhuman primates.

J. Wilson, D. Sterman, A. Elshami, 1996, Human gene therapy.

Cell Transplantation in Liver-Directed Gene Therapy

J. Wilson, S. Raper, S. Raper, 1993, Cell transplantation.

Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors.

J. Wilson, G. Gao, J. Tazelaar, 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

Adenoviral vector-mediated insulin gene transfer in the mouse pancreas corrects streptozotocin-induced hyperglycemia

S. Raper, S. Raper, Alexander L. Shifrin, 2001, Gene Therapy.

Targeted retroviral gene transfer into the rat biliary tract

James M. Wilson, J. Wilson, S. Raper, 1996, Somatic cell and molecular genetics.

Gene transfer into the liver of nonhuman primates with E1-deleted recombinant adenoviral vectors: safety of readministration.

E. Furth, J. Wilson, S. Raper, 1999, Human gene therapy.

Intracranial administration of adenovirus expressing HSV-TK in combination with ganciclovir produces a dose-dependent, self-limiting inflammatory response.

D. Hackney, K. Judy, J. Wilson, 1997, Human gene therapy.

Developing adenoviral-mediated in vivo gene therapy for ornithine transcarbamylase deficiency

M. Yudkoff, J. Wilson, S. Raper, 1998, Journal of Inherited Metabolic Disease.

Safety and feasibility of liver-directed ex vivo gene therapy for homozygous familial hypercholesterolemia.

D. Rader, B. Clark, J. Wilson, 1996, Annals of surgery.

An approach for treating the hepatobiliary disease of cystic fibrosis by somatic gene transfer.

J. Wilson, S. Raper, J. Engelhardt, 1993, Proceedings of the National Academy of Sciences of the United States of America.

Gene therapy for human liver disease.

J. Wilson, S. Raper, 1995, Progress in liver diseases.

Genotype spectrum of ornithine transcarbamylase deficiency: correlation with the clinical and biochemical phenotype.

M. Tuchman, M. Yudkoff, James M. Wilson, 2000, American journal of medical genetics.

Recombinant adenovirus gene transfer in adults with partial ornithine transcarbamylase deficiency (OTCD).

M. Yudkoff, J. Wilson, S. Raper, 1999, Human gene therapy.

Evaluating the potential of germ line transmission after intravenous administration of recombinant adenovirus in the C3H mouse.

J. Wilson, G. Gao, S. Raper, 1998, Human gene therapy.

Selective gene transfer into the liver of non-human primates with E1-deleted, E2A-defective, or E1-E4 deleted recombinant adenoviruses.

E. Furth, J. Wilson, G. Gao, 1998, Human gene therapy.

In vivo correction of low density lipoprotein receptor deficiency in the Watanabe heritable hyperlipidemic rabbit with recombinant adenoviruses.

J. Wilson, S. Raper, S. Raper, 1994, The Journal of biological chemistry.

Constitutive and regulated expression of processed insulin following in vivo hepatic gene transfer

T. Clackson, G. Gao, S. Raper, 2002, Gene Therapy.

Transplantation of genetically modified autologous hepatocytes into nonhuman primates: feasibility and short-term toxicity.

James M. Wilson, J. Wilson, S. Raper, 1992, Human gene therapy.

Retroviral-mediated gene transfer in human hepatocytes.

J. Wilson, S. Raper, M. Grossman, 1992, Surgery.

Making space for intestinal gene therapy.

J. Wilson, S. Raper, 1997, Gastroenterology.

A novel approach for introducing hepatocytes into the portal circulation.

S. Raper, M. Grossman, J. M. Wilson, 1993, The Journal of laboratory and clinical medicine.

Generation of a mouse expressing a conditional knockout of the hepatocyte growth factor gene: demonstration of impaired liver regeneration.

James M. Wilson, S. Raper, S. Raper, 2004, DNA and cell biology.

A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia

D. Rader, B. Clark, H. Brewer, 1995, Nature Medicine.